NCT01324206 Development of 3T Magnetic Resonance Research Methods for NIA Studies
| NCT ID | NCT01324206 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Institute on Aging (NIA) |
| Condition | Normal Physiology |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2008-11-03 |
| Primary Completion | — |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2008-11-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background: \- Magnetic resonance imaging (MRI) studies provide important information on the structure and function of various body systems, including the brain, muscles, joints, heart, and blood vessels. Scientific applications of MRI scans often use techniques that need to be modified or refined before they are used in clinical studies. To develop and modify these techniques for the new Philips 3T Achieva whole-body MRI scanner, researchers are interested in conducting trial MRI scans on healthy individuals and individuals with conditions that require imaging studies. Objectives: \- To conduct preliminary trials of the 3T MRI facility to develop and refine MRI scanning procedures. Eligibility: \- Individuals at least 18 years of age who are able to have magnetic resonance imaging. Design: * Participants will be screened with a full medical history and physical examination, as well as blood and urine tests. * Participants will have an MRI scan using the 3T scanner. Some scans may require the use of a contrast agent or radiotracer, which is a small amount of radioactive substance that will be injected before the start of the scan. Some participants may be asked to perform tasks of thinking and movement while in the scanner, in order to test the procedures required for a functional MRI scan. * No treatment will be provided as part of this protocol.
Eligibility Criteria
* INCLUSION CRITERIA: To be eligible to participate in this study, an individual must meet all the following criteria: * Ability of subject to understand the study and stated willingness to comply with all study procedures. * Male or female, age \> 18years. * Able to speak and read English. * Capable of providing informed consent. * Subjects or persons identified by an investigator to have a condition of interest for exploratory studies as it relates to aging. These participants are not being scanned for diagnostic purposes. EXCLUSION CRITERIA: An individual who meets any of the following criteria will be excluded from participation in this study: * Has condition and/or non-removable device contraindicated for MRI as per the MRI eligibility form. * Weight \> 300lbs (MRI scanner weight limit) * Is currently pregnant or a nursing mother.
Contact & Investigator
Mustapha Bouhrara, Ph.D.
PRINCIPAL INVESTIGATOR
National Institute on Aging (NIA)
Frequently Asked Questions
Who can join the NCT01324206 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Normal Physiology. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01324206 currently recruiting?
Yes, NCT01324206 is actively recruiting participants. Contact the research team at sarah.park@nih.gov for enrollment information.
Where is the NCT01324206 trial being conducted?
This trial is being conducted at Baltimore, United States.
Who is sponsoring the NCT01324206 clinical trial?
NCT01324206 is sponsored by National Institute on Aging (NIA). The principal investigator is Mustapha Bouhrara, Ph.D. at National Institute on Aging (NIA). The trial plans to enroll 1,000 participants.